Renascience Inc. Logo

Renascience Inc.

Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.

4889 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
仙台市青葉区星陵町2−1
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Renascience Inc. is a research and development company engaged in the development and commercialization of pharmaceuticals and medical devices. The company focuses on creating innovative treatments derived from basic research to address various medical issues, including diseases associated with aging and hereditary conditions. Its R&D pipeline includes new drug candidates, such as antisense oligonucleotides, and advanced medical technology, such as a programmed medical device that utilizes artificial intelligence (AI) to support hemodialysis. Renascience actively forms strategic collaborations with pharmaceutical partners and academic institutions to advance its development projects and bring novel therapies to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 08:37
Regulatory News Service
確認書
Japanese 8.7 KB
2025-09-03 08:30
Regulatory News Service
訂正有価証券報告書-第26期(2024/04/01-2025/03/31)
Japanese 1.7 MB
2025-06-27 08:35
Post-Annual General Meeting Information
臨時報告書
Japanese 23.6 KB
2025-06-24 08:36
Governance Information
内部統制報告書-第26期(2024/04/01-2025/03/31)
Japanese 23.2 KB
2025-06-24 08:35
Registration Form
確認書
Japanese 8.7 KB
2025-06-24 08:33
Registration Form
有価証券報告書-第26期(2024/04/01-2025/03/31)
Japanese 3.5 MB
2024-11-14 07:37
Interim Report
確認書
Japanese 8.7 KB
2024-11-14 07:36
Interim Report
半期報告書-第26期(2024/04/01-2025/03/31)
Japanese 288.9 KB
2024-06-28 04:56
Post-Annual General Meeting Information
臨時報告書
Japanese 24.5 KB
2024-06-28 04:32
Governance Information
内部統制報告書-第25期(2023/04/01-2024/03/31)
Japanese 22.7 KB
2024-06-28 04:26
Registration Form
確認書
Japanese 8.7 KB
2024-06-28 04:24
Annual Report
有価証券報告書-第25期(2023/04/01-2024/03/31)
Japanese 3.5 MB
2024-05-27 10:10
Board/Management Information
臨時報告書
Japanese 22.4 KB
2024-02-08 07:46
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-02-08 07:45
Quarterly Report
四半期報告書-第25期第3四半期(2023/10/01-2023/12/31)
Japanese 235.8 KB

Automate Your Workflow. Get a real-time feed of all Renascience Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Renascience Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.